Analystreport

Heron Therapeutics, Inc. (NASDAQ: HRTX) had its price target lowered by analysts at Cantor Fitzgerald from $20.00 to $12.00.

Heron Therapeutics, Inc.  (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home